Company profile for Judo Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Judo Bio is a biopharmaceutical company at the forefront of developing precision therapeutics for diseases driven by genetic mutations. Specializing in targeted therapies, Judo Bio harnesses advanced molecular biology techniques to create treatments that address the root causes of various genetic and oncology-related conditions. With a robust pipeline focused on highly specific and potent solutions, Judo Bio is dedicated to de...
Judo Bio is a biopharmaceutical company at the forefront of developing precision therapeutics for diseases driven by genetic mutations. Specializing in targeted therapies, Judo Bio harnesses advanced molecular biology techniques to create treatments that address the root causes of various genetic and oncology-related conditions. With a robust pipeline focused on highly specific and potent solutions, Judo Bio is dedicated to delivering transformative therapies that improve patient outcomes and address unmet medical needs in precision medicine.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
300 Technology Square, 8th Floor Cambridge, MA 02139
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/08/3184070/0/en/Judo-Bio-s-Megalin-STRIKERs-Achieve-First-Demonstration-of-Functional-Pharmacodynamic-Effects-from-Kidney-Selective-Gene-Silencing-in-Non-Human-Primates.html

GLOBENEWSWIRE
08 Nov 2025

https://www.globenewswire.com/news-release/2025/10/20/3169298/0/en/Judo-Bio-Presents-Data-Demonstrating-Sustained-Kidney-Selective-Gene-Silencing-Across-Species.html

GLOBENEWSWIRE
20 Oct 2025

https://www.businesswire.com/news/home/20241026856697/en

BUSINESSWIRE
26 Oct 2024

https://www.businesswire.com/news/home/20241011422908/en

BUSINESSWIRE
11 Oct 2024

https://www.biopharmadive.com/news/judo-bio-kidney-sirna-series-a-launch/728877/

BIOPHARMADIVE
08 Oct 2024

https://www.businesswire.com/news/home/20241007232821/en

BUSINESSWIRE
07 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty